Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Fixed Capital/Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.060.520.520.400.32

What is the latest Fixed Capital/Sales ratio of MANKIND PHARMA ?

The latest Fixed Capital/Sales ratio of MANKIND PHARMA is 1.06 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.06
Mar20240.52
Mar20230.52
Mar20220.40
Mar20210.32

How is Fixed Capital/Sales of MANKIND PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.06
103.85
Mar2024 0.52
0.00
Mar2023 0.52
30.00
Mar2022 0.4
25.00
Mar2021 0.32 -

Other Financial Ratios of MANKIND PHARMA


Compare Fixed Capital/Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹85,835.6 Cr 1.9% -7.1% -15.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,370.0 Cr -3.9% -8.9% -3.2% Stock Analytics
DIVIS LABORATORIES ₹161,193.0 Cr 3.8% -4.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,438.0 Cr 3.2% -5.6% 26.6% Stock Analytics
DR REDDYS LABORATORIES ₹103,097.0 Cr 3.3% -6% 11% Stock Analytics
CIPLA ₹97,846.7 Cr 0.8% -9.1% -13.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.9%

-7.1%

-15.2%

SENSEX

3.7%

-0.9%

0.7%


You may also like the below Video Courses